Research Direction
Creating innovative therapeutic solutions from in-depth understanding of disease biology
Dr. Yunlong Du <br>CEO and CMO (Partner, Director)
• Responsible for strategy development, overall operation and clinical management of the Company
• Having led the R&D, NDA preparation and submission of several projects of Hua Medicine, and successfully assisting the company to be listed in Hong Kong in 2018
• More than 20 years of experience in early stage R&D, clinical development and the overall process of product launch in famous multinational pharmaceutical companies such as Pfizer and GSK.
• Having managed several Phases 1-4 clinical trials, medical affairs, and drug safety management in the therapeutic areas of dermatology, metabolism and neurology, and participated in the preparation and submission of several NDAs
• MD, Albany Medical College, US, Bachelor of Medicine, Peking University, US; Certified Professional Medical Practitioner in the United States.
• Having been included in Shanghai's "Thousand Talents Plan", with 15 invention patents and more than 20 publications.
Keywords:
Contacts
Add: 5-6/F, Tower B, Chongxin Building, No.13, Hangfeng Road, Fengtai District, Beijing
Tel: 010-83141848
Email: pg@primegene.net
Official WeChat
Copyright © 2021 Beijing Prime Gene Therapeutics Co., Ltd. All Rights Reserved. 京ICP备2022001152号-1 300.cn Beijing